Financial Statements — BBLG
Balance Sheet
(in millions USD)| Metric | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Cash & Equivalents | -- | -- | -- | -- | -- | -- | -- | -- | -- | 6.19 | -- | -- | 5.81 | 0.00 | 0.00 | 0.07 |
| Total Current Assets | 4.98 | 6.35 | 7.00 | 3.16 | 4.07 | 3.19 | 3.84 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-current Assets* | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Assets | 4.98 | 6.35 | 7.00 | 3.16 | 4.07 | 3.19 | 3.84 | 4.98 | 7.62 | 6.78 | 5.20 | 5.66 | 6.09 | 0.05 | 0.00 | 0.07 |
| Accounts Payable | 0.31 | 0.33 | 0.40 | 0.25 | 0.19 | 0.23 | 0.15 | 1.10 | 1.69 | 2.28 | 0.80 | 0.07 | 0.05 | 0.07 | 0.08 | 0.50 |
| Total Current Liabilities | 0.31 | 0.33 | 0.41 | 0.25 | 0.27 | 0.28 | 0.16 | 1.18 | 1.93 | 4.01 | -- | -- | -- | -- | -- | -- |
| Total Non-current Liabilities* | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- | -- | -- | -- | -- | -- |
| Total Liabilities | 0.31 | 0.33 | 0.41 | 0.25 | 0.27 | 0.28 | 0.16 | 1.18 | 1.93 | 4.01 | 0.80 | 0.07 | 0.05 | 15.18 | 14.62 | 14.20 |
| Retained Earnings | (88.90) | (87.45) | (86.78) | (86.04) | (83.50) | (82.56) | (81.77) | (79.36) | (77.44) | (75.67) | (72.85) | (71.63) | (71.17) | (70.30) | (69.79) | (69.30) |
| Total Stockholder Equity | 4.67 | 6.02 | 6.60 | 2.91 | 3.79 | 2.91 | 3.67 | 3.79 | 5.69 | 2.77 | 4.40 | 5.59 | 6.04 | (15.13) | (14.62) | (14.12) |
* Derived from reported values
Income Statement
(in billions USD) (except per-share rows)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 |
|---|
| Total Revenue | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling, General & Admin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Pretax Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax Provision | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -0.00 | 0.00 | -- | -- | -- |
| Net Income | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Basic EPS | (0.43) | (0.63) | (0.37) | (1.33) | (0.32) | (1.82) | (2.37) | 0.67 | (1.31) | (31.48) | (0.61) | (1.69) | (0.23) | 0.11 | (0.12) | (0.05) | (0.07) | -- | -- | -- |
| Diluted EPS | (0.43) | (0.63) | (0.37) | (1.33) | (0.32) | (1.82) | (2.37) | 0.67 | (1.31) | (29.33) | (0.61) | (1.69) | -- | -- | -- | -- | -- | -- | -- | -- |
Cash Flow Statement
(in millions USD)| Metric | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 | Q2
2021 |
|---|
| Operating Cash Flow | (0.80) | (0.71) | (0.59) | (0.46) | (0.93) | (1.35) | (0.57) | (0.90) | (1.30) | (2.02) | (2.56) | (3.63) | (1.35) | (1.95) | (0.40) | (0.36) | (0.86) | (0.19) | (0.28) | (0.64) |
| Financing Cash Flow | -- | 0.00 | 0.00 | 4.35 | 0.35 | 1.11 | 1.81 | 0.00 | 1.50 | 0.59 | 0.00 | 4.45 | -- | -- | -- | -- | -- | 6.86 | 0.28 | 0.57 |
